» Articles » PMID: 29752172

Social Determinants of Health Are Associated with Markers of Renal Injury in Adolescents with Type 1 Diabetes

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2018 May 13
PMID 29752172
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the relationship between the social determinants of health and markers of early renal injury in adolescent patients with type 1 diabetes (T1D).

Study Design: Renal outcomes included estimated glomerular filtration rate (eGFR) and albumin-creatinine excretion ratio (ACR). Differences in urinary and serum inflammatory markers also were assessed in relation to social determinants of health. Regression analysis was used to evaluate the association between the Ontario Marginalization Index (ON-Marg) as a measure of the social determinants of health, patient characteristics, ACR, eGFR, and renal filtration status (hyperfiltration vs normofiltration).

Results: Participants with T1D (n = 199) with a mean age of 14.4 ± 1.7 years and diabetes duration of 7.2 ± 3.1 years were studied. Mean eGFR was 122.0 ± 19.4 mL/min/1.73 m. Increasing marginalization was positively associated with eGFR (P < .0001) but not with ACR (P = .605). Greater marginalization was associated with greater median levels of urinary interleukin (IL)-2, IL-12 (p40), macrophage-derived chemokine, monocyte chemoattractant protein-3, and tumor necrosis factor-β and serum IL-2. ON-Marg was significantly associated with eGFR after we controlled for age, sex, body mass index z score, ethnicity, serum glucose, and hemoglobin A1c in linear regression. A similar association between hyperfiltration and ON-Marg score was observed in multivariable logistic regression.

Conclusion: Increasing marginalization is significantly associated with both eGFR and hyperfiltration in adolescents with T1D and is associated with significant changes in urinary inflammatory biomarkers. These findings highlight a potentially important interaction between social and biological determinants of health in adolescents with T1D.

Citing Articles

Parent and adolescent perspectives on a novel transdisciplinary model of healthcare delivery for type 1 diabetes.

Pierce J, Enlow P, Thomas C, Price J, Rachel W, Wysocki T Clin Pract Pediatr Psychol. 2024; 12(3):279-290.

PMID: 39310916 PMC: 11415229. DOI: 10.1037/cpp0000512.


Exploring Mediators of Mental Health Service Use Among Transgender Individuals in Ontario, Canada.

Abramovich A, Gould W, Pang N, de Oliveira C, Iwajomo T, Vigny-Pau M Can J Psychiatry. 2023; 68(12):933-948.

PMID: 37165522 PMC: 10657585. DOI: 10.1177/07067437231171541.


Complications in Diabetes Mellitus: Social Determinants and Trends.

Cuddapah G, Chennakesavulu P, Pentapurthy P, Vallakati M, Kongara A, Reddivari P Cureus. 2022; 14(4):e24415.

PMID: 35619856 PMC: 9126423. DOI: 10.7759/cureus.24415.


What can we learn from β-cell failure biomarker application in diabetes in childhood? A systematic review.

Calderon-Hernandez M, Altamirano-Bustamante N, Revilla-Monsalve C, Mosquera-Andrade M, Altamirano-Bustamante M World J Diabetes. 2021; 12(8):1325-1362.

PMID: 34512897 PMC: 8394223. DOI: 10.4239/wjd.v12.i8.1325.


The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy.

Chang T, Chen J Int J Mol Sci. 2020; 21(9).

PMID: 32365893 PMC: 7246426. DOI: 10.3390/ijms21093172.


References
1.
Kakleas K, Kandyla B, Karayianni C, Karavanaki K . Psychosocial problems in adolescents with type 1 diabetes mellitus. Diabetes Metab. 2009; 35(5):339-50. DOI: 10.1016/j.diabet.2009.05.002. View

2.
Thomas M, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm K, Zoungas S . Diabetic kidney disease. Nat Rev Dis Primers. 2016; 1:15018. PMC: 7724636. DOI: 10.1038/nrdp.2015.18. View

3.
Raphael D . Poverty in childhood and adverse health outcomes in adulthood. Maturitas. 2011; 69(1):22-6. DOI: 10.1016/j.maturitas.2011.02.011. View

4.
Halfon N, Larson K, Russ S . Why social determinants?. Healthc Q. 2010; 14 Spec No 1:8-20. DOI: 10.12927/hcq.2010.21979. View

5.
Shlipak M, Matsushita K, Arnlov J, Inker L, Katz R, Polkinghorne K . Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013; 369(10):932-43. PMC: 3993094. DOI: 10.1056/NEJMoa1214234. View